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xfoliation, which is the detachment of infected epi-
thelial cells, is an innate defense mechanism to
prevent bacterial colonization. Indeed, infection with
 
Neisseria gonorrhoeae
 
 induced epithelial detachment
from an extracellular matrix (ECM) substrate in vitro. Sur-
prisingly, variants of 
 
N. gonorrhoeae
 
 that bind to human
carcinoembryonic antigen-related cell adhesion molecules
(CEACAMs) failed to induce detachment and, instead,
promoted enhanced host cell adhesion to the ECM. Micro-
array analysis revealed that CEACAM engagement by
several human pathogens triggers expression of CD105.
Blockage of CD105 expression by antisense oligonucleo-
E
 
tides abolished infection-induced cell adhesion. The
expression of full-length CD105 promoted cell adhesion to
the ECM and was sufﬁcient to prevent infection-induced
detachment. The CD105-mediated increase in cell adhesion
was dependent on the presence and function of integrin
 
 
 
1. CD105 expression did not elevate cellular integrin
levels but caused a dramatic increase in the ECM-binding
capacity of the cells, suggesting that CD105 affects integrin
activity. The exploitation of CEACAMs to trigger CD105
expression and to counteract infection-induced cell detach-
ment represents an intriguing adaptation of pathogens
that are specialized to colonize the human mucosa.
 
Introduction
 
Colonization of mucosal surfaces, which is the initial key step
in the pathogenesis of diverse bacterial pathogens, requires the
attachment of microorganisms to host surface structures (Finlay
and Falkow, 1997; Abraham et al., 1998). As a countermeasure,
epithelial cells can undergo exfoliation, which is an innate
defense mechanism that is characterized by detachment of the
infected cell (Mulvey et al., 2000). Exfoliation occurs as a
rapid cellular response to bacteria and effectively lowers the in-
fectious load (Apicella et al., 1996; Mulvey et al., 1998, 2000).
Also, in the case of 
 
Neisseria gonorrhoeae
 
, which is the caus-
ative agent of gonorrhea and a paradigmatic colonizer of human
mucosa, the exfoliation of infected epithelial cells has been
documented in vitro and in vivo (Ward et al., 1974; Evans,
1977; Melly et al., 1981; Apicella et al., 1996; Mosleh et al.,
1997). Although the nature of the signal that induces exfoliation
in vivo is unknown, the detachment of epithelial cells can be
induced by soluble Neisserial products such as lipo-oligo-
saccharide in organ cultures (Melly et al., 1981).
Despite host cell exfoliation, 
 
N. gonorrhoeae
 
 is highly
successful in establishing itself on epithelial surfaces of the
human body. Gonococci express an array of adhesive factors
that together allow for multiple, independent host cell inter-
actions (Dehio et al., 2000). Although the exquisite host adaptation
of 
 
N. gonorrhoeae
 
 has restricted in vivo experimentation,
a limited number of volunteer studies and extensive in vi-
tro experiments have suggested an orchestrated sequence of
events upon infection. In particular, these investigations have
pointed to type IV pili, which are filamentous surface appendages
of microorganisms, to establish initial bacterial contact with
the mucosa (Dehio et al., 2000). Furthermore, the expression
of another group of outer membrane proteins, the so-called
colony opacity-associated (Opa) proteins, appears to mediate
intimate binding of bacteria to host cells. Although Opa pro-
tein expression is subject to phase variation, the opaque
phenotype dominates in vivo because mainly Opa-expressing
variants are reisolated from volunteers even when nonopaque
gonococci are used for infection (Swanson et al., 1988; Jerse
et al., 1994).
 
Correspondence to Christof R. Hauck: christof.hauck@mail.uni-wuerzburg.de
Abbreviations used in this paper: CEACAM, carcinoembryonic antigen-related
cell adhesion molecule; CS, calf serum; CV, crystal violet; MOI, multiplicity of
infection; Opa, opacity associated; ZRP-1, zyxin-related protein 1.
The online version of this article contains supplemental material. 
JCB • VOLUME 170 • NUMBER 5 • 2005 826
 
Work over the last decade has identified cellular receptors
that are targeted by Opa proteins from 
 
N. gonorrhoeae
 
 and its
close relative 
 
Neisseria meningitidis
 
, which is a major cause of
bacterial meningitis and is a common colonizer of nasopharyn-
geal mucosa (for review see Hauck and Meyer, 2003). Besides
a few Opa proteins that recognize heparansulfate proteoglycans
(Opa
 
HSPG
 
), most gonococcal and meningococcal Opa proteins
that have been characterized so far recognize members of the
human carcinoembryonic antigen-related cell adhesion mole-
cule (CEACAM) family (Opa
 
CEA
 
). Opa
 
CEA
 
–CEACAM associa-
tion involves two of the four extracellular loops of outer mem-
brane–embedded Opa proteins and the unglycosylated face
of the NH
 
2
 
-terminal Ig variable-like domain of CEACAM1,
CEACAM3, CEA (the product of the CEACAM5 gene), or
CEACAM6 (Bos et al., 1999, 2002; Virji et al., 1999).
Epithelial cells express the transmembrane receptor
CEACAM1 as well as glycosylphosphatidylinositol-linked CEA
and CEACAM6, which usually localize to the apical mem-
brane domain (Hammarstrom, 1999). The in vivo function of
CEACAMs on epithelia is not clear, though some family mem-
bers can mediate cell–cell adhesion in vitro (Benchimol et al.,
1989). It is important to note that only a few CEACAM homo-
logues are present in rodents, whereas the CEACAM family
has expanded considerably during primate evolution and is still
diversifying (Hammarstrom and Baranov, 2001; Zhou et al.,
2001). As these glycoproteins are recognized by a variety of
gram-negative bacteria that are found in association with hu-
man mucosa (Leusch et al., 1991; Sauter et al., 1993; Virji et
al., 1996, 2000; Toleman et al., 2001; Hill and Virji, 2003), it
has been speculated that CEACAMs regulate bacterial coloni-
zation; however, direct evidence for this hypothesis is lacking
(Hammarstrom and Baranov, 2001).
In this study, we demonstrate that CEACAM engagement
by bacterial pathogens triggers enhanced host cell adhesion to
the ECM, thereby abrogating cell detachment, which is an es-
sential component of the exfoliation response. Enhanced cell
adhesion depends on de novo expression of CD105, a TGF-
 
 
 
1
receptor. Moreover, bacteria-triggered CD105 surface expres-
sion is necessary and sufficient to prevent detachment of in-
fected cells by modulating integrin affinity. These results not
only provide, for the first time, molecular insight into microbial
strategies that counteract epithelial exfoliation but, in addition,
help to explain the prevalence of CEACAM recognition amongst
human pathogens.
 
Results
 
Opa
 
CEA
 
-expressing gonococci induce 
enhanced epithelial cell adhesion
 
To analyze the interaction of 
 
N. gonorrhoeae
 
 with target tissues,
we used the human cervix-derived epithelial cell line ME-
180, which is an established model system that allows pilus-
and Opa protein–mediated gonococcal adhesion (Rudel et al.,
1992; Kupsch et al., 1993; Scheuerpflug et al., 1999). When
confluent monolayers of ME-180 cells were infected for 
 
 
 
8 h
with piliated gonococci, the infected cells detached from the
culture dish, whereas ME-180 cells that were infected with
Opa
 
CEA
 
-expressing gonococci did not detach (unpublished
data). To investigate this cellular response in more detail, scan-
ning EM was performed on monolayers of ME-180 cells that
were infected for 14 h. In contrast to uninfected cells, cells that
were infected with piliated gonococci or nonpiliated Opa
 
HSPG
 
-
expressing pathogens released cell–cell contacts and acquired a
rounded morphology that was consistent with bacteria-induced
cell detachment (Fig. 1 A). Strikingly, cells that were infected
with CEACAM-binding gonococci remained attached through-
out the 14 h of infection, although they showed reduced num-
bers of cell–cell contacts (Fig. 1 A, arrows). When the sam-
ples were inverted and centrifuged before fixation to remove
loosely attached cells, 
 
 
 
45–60% of ME-180 cells that were in-
fected with Opa
 
HSPG
 
-expressing nonopaque, or piliated gono-
cocci had detached (Fig. 1 B). Centrifugation also removed
Figure 1. OpaCEA-expressing N. gonorrhoeae triggers enhanced epithelial
cell adhesion. (A) Confluent layers of ME-180 cells were left uninfected or
were infected for 14 h with piliated, nonopaque (Ngo P ), nonpiliated
OpaHSPG-expressing (Ngo OpaHSPG), or nonpiliated OpaCEA-expressing N.
gonorrhoeae MS11 (Ngo OpaCEA). Cultures were fixed in situ and were
analyzed by scanning EM. Arrows highlight cell–cell contacts. (B) Confluent
layers of ME-180 cells were infected for 14 h with the indicated bacterial
strains. Cells were used in detachment assays, were fixed and stained,
and the percentage of detached cells was determined. (C) Aliquots of
detachment assays performed as in B were plated after 14 h of infection
onto GC agar plates, and the resulting bacterial colonies were counted.
(D) ME-180 cells were infected with the indicated gonococcal variants or
were left uninfected. After 8 h, cells were used in adhesion assays. Adherent
cells were fixed and stained with CV. Error bars represent means   SD of
five wells (B) and four determinations (C) or represent mean staining inten-
sity   SD of five wells (D). 
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15–20% of ME-180 cells from uninfected cultures; however,
cells infected with Opa
 
CEA
 
-expressing gonococci almost com-
pletely stayed attached to collagen-coated culture dishes (Fig. 1
B). Importantly, all gonococcal variants exhibited the same
growth properties in the cell culture medium (Fig. 1 C), sug-
gesting that the lack of cell detachment after infection with
Opa
 
CEA
 
-expressing bacteria was not a result of differences in
total bacterial load. As infection with Opa
 
CEA
 
-expressing gono-
cocci seemed to reduce the amount of cell–cell contacts (Fig. 1
A), we speculated that these bacteria stimulate increased cell
matrix adhesion. Indeed, when ME-180 cells were used in an
adhesion assay 8 h after infection, cells that were infected with
Opa
 
CEA
 
 gonococci showed dramatically enhanced cell adhesion
to collagen compared with uninfected cells or with cells in-
fected with nonopaque gonococci (Fig. 1 D).
 
Gonococcus-induced epithelial cell 
adhesion requires CEACAM-initiated 
signaling and host gene expression
 
To investigate whether Opa
 
CEA
 
-mediated stimulation of epithe-
lial CEACAMs was responsible for increased cell adhesion, we
infected the CEACAM-negative human 293T cell line with
Opa
 
CEA
 
 gonococci (Ergun et al., 2000; Schmitter et al., 2004).
Adhesion of these cells was unaltered by bacterial infection
(Fig. 2 A). However, when 293T cells were transfected with
cDNA encoding either CEACAM1 or 6, infection with Opa
 
CEA
 
gonococci led to increased cell adhesion on a collagen matrix
(Fig. 2, A and B). In contrast, neither isogenic nonopaque
or piliated gonococci nor nonpathogenic 
 
Neisseria
 
 
 
cinerea
 
induced enhanced adhesion of CEACAM-expressing cells.
Clearly, CEACAM1 or 6 expression in the absence of bacterial
infection did not lead to alterations in cell adhesion (Fig. 2, A
and B). Also, cell adhesion to an uncoated cell culture dish was
not affected by any of the aforementioned conditions (Fig. 2, A
and B). Increased cell adhesion in response to Opa
 
CEA
 
 
 
N. gon-
orrhoeae
 
 correlated with the ability of CEACAM1-expressing
293T cells to withstand detachment after prolonged infection,
whereas infection of these cells with nonopaque gonococci re-
sulted in cell detachment (Fig. 2 C). Interestingly, the increase
in 293T cell adhesion in response to Opa
 
CEA
 
 bacteria was abol-
ished when host cell kinases were inhibited by staurosporine
(Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200412151/DC1) or when protein translation in the eukary-
otic cell was blocked by cycloheximide (Fig. 2 D). These re-
sults suggested that CEACAM engagement by Opa
 
CEA
 
 proteins
of pathogenic 
 
N. gonorrhoeae
 
 stimulates signaling and gene
expression events in the host cell that lead to altered cell adhe-
sion and prevent detachment of infected cells.
 
Bacterial engagement of CEACAMs 
stimulates expression of specific host 
cell genes
 
To identify factors that are responsible for enhanced host cell
adhesion, we analyzed bacteria-triggered gene expression in
CEACAM1- or 6-transfected cells by cDNA microarrays.
RNA was isolated from CEACAM1- or 6-expressing 293T
cells that were infected or left uninfected with Opa
 
CEA
 
 
 
N. gon-
orrhoeae
 
. mRNA was transcribed in cDNA and labeled with
Cy3 or Cy5, respectively, and the labeled samples were com-
pared with each other as outlined in Fig. S2 (available at http://
www.jcb.org/cgi/content/full/jcb.200412151/DC1). In total,
the expression of 20 genes was consistently up-regulated 
 
 
 
1.8-
fold in response to CEACAM1 stimulation by Opa
 
CEA
 
 gono-
cocci, whereas the expression of 57 genes was enhanced 90
min after infection of CEACAM6-expressing cells. When the
two datasets were combined, a common set of nine genes
was identified to be up-regulated 
 
 
 
1.8-fold upon bacterial
CEACAM stimulation (Table I). Assuming that the factor
responsible for enhanced cell adhesion is identical in both
CEACAM1- and 6-expressing cells and that it is connected to
Figure 2. Enhanced cell adhesion upon infection depends
on host cell CEACAMs and de novo protein synthesis.
(A) 293T cells were transfected with control vector
(pcDNA) or CEACAM1; were infected or left uninfected
for 8 h with piliated N. gonorrhoeae (Ngo P ), non-
opaque N. gonorrhoeae (Ngo Opa ), OpaCEA N. gon-
orrhoeae (Ngo OpaCEA), or N. cinerea; and were used in
an adhesion assay. (B) 293T cells were transfected with
empty vector (pcDNA) or CEACAM6, were infected for
8 h with indicated bacteria, and were used in an adhe-
sion assay. (C) 293T cells were transfected with control
vector (pcDNA) or CEACAM1 and were infected for 14 h
with indicated bacteria. Infected cultures were gently washed
to remove loosely attached cells, and adherent cells were
fixed and stained with CV. Pictures show representative
fields of view. (D) 293T cells transfected as in C were
infected for 8 h with Ngo OpaCEA in the presence of in-
creasing amounts of cycloheximide (Chx) and were used
in adhesion assays. (A, B, and D) Error bars represent
means   SD of five wells. 
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cell adhesion, we concentrated on CD105 (endoglin), which is
a member of the TGF-
 
 
 
1 receptor family that has been linked
to cell migration and organization of cell adhesion sites (Liu et
al., 2002; Conley et al., 2004; Sanz-Rodriguez et al., 2004).
CD105 mRNA was increased about two- to threefold in
CEACAM1- or 6-expressing cells, respectively, 90 min after
infection with Opa
 
CEA
 
 gonococci (Table I and Fig. S2).
 
CEACAM1 and 6 engagement stimulate 
CD105 expression
 
To verify the results of the microarray screen, semiquantitative
RT-PCR was performed on RNA samples that were isolated
from control- (pcDNA) or CEACAM1-transfected 293T cells
before or after infection. CD105 mRNA levels were found to
specifically increase about four- to sixfold 8 h after infection of
CEACAM1-expressing cells with CEACAM-binding gono-
cocci (Fig. 3 A). As an internal control, an 
 
 
 
350-bp fragment
of 
 
 
 
-actin was coamplified. In addition, the same set of primers
was used on a plasmid template containing full-length CD105
cDNA as a positive control (Fig. 3 A). Western blotting of ly-
sates from transfected 293T cells confirmed the expression of
CEACAM1 (Fig. 3 B). When ME-180 cervix carcinoma cells
that endogenously express CEACAM1 (Fig. 3 B) were infected
with Opa
 
CEA
 
-expressing gonococci, a similar up-regulation of
CD105 mRNA was observed (Fig. 3 A). The up-regulation of
CD105 was also observed after the infection of CEACAM6-
expressing cells with Opa
 
CEA
 
 gonococci, which is consistent
with the microarray analysis (Fig. 3 D). CEACAM6 is an-
chored to the plasma membrane via a glycosylphosphatidyl-
inositol moiety, suggesting that a cytoplasmic domain is not re-
quired to initiate CD105 up-regulation. Indeed, deletion of the
cytoplasmic domain of CEACAM1 did not alter its ability to
induce an increase in CD105 mRNA in response to infection
with Opa
 
CEA
 
 
 
N. gonorrhoeae
 
 (Fig. 3 E). Together, these data
corroborated the findings of the microarray analysis. Further-
more, the results suggested that, as reported for CEACAM1-
and 6-mediated bacterial internalization (Billker et al., 2002),
CEACAM-initiated CD105 expression does not require the
presence of a cytoplasmic domain.
 
Diverse CEACAM-binding human 
pathogens trigger CD105 expression
 
To verify that CD105 mRNA up-regulation in CEACAM-
expressing cells was a specific result of CEACAM engagement
by pathogens, cells were infected with different bacterial strains.
Importantly, the increase of CD105 mRNA in CEACAM1-
positive cells depended on the correct phenotype of the bacte-
ria, as piliated but nonopaque gonococci did not induce CD105
expression (Fig. 4 A). In addition to 
 
N. gonorrhoeae
 
 and the
closely related 
 
N. meningitidis
 
 that use Opa proteins to engage
CEACAMs, several other human-specific bacterial pathogens
 
Table I.
 
 Gene expression events that are common to Opa
 
CEA
 
-mediated 
engagement of CEACAM1 or 6
 
-fold induction
 
a
 
Gene Description CEACAM1 CEACAM6
 
CRIM Cysteine-rich motor neuron 2.2 
 
 
 
 0.1 4.6 
 
 
 
 1.7
ENG CD105 (endoglin) 1.9 
 
 
 
 0.3  2.9 
 
 
 
 0.5
EPHB3 EphB3 2.1 
 
 
 
 0.3 3.0 
 
 
 
 0.9
GIT1
G protein–coupled receptor
kinase interactor 1 1.9 
 
 
 
 0.3 2.6 
 
 
 
 0.9
KIAA1321 KIAA1321 protein 2.2 
 
 
 
 0.5 3.0 
 
 
 
 1.2
KIAA0720 KIAA0720 protein 2.7 
 
 
 
 0.6 2.2 
 
 
 
 0.6
MMP17 Matrix metalloprotease 17 1.9 
 
 
 
 0.3 2.5 
 
 
 
 0.4
SQV7L
Nucleotide sugar transporter
similar to 
 
C. elegans
 
 sqv7 2.3 
 
 
 
 0.5 2.6 
 
 
 
 0.4
TCEB1
Transcription elongation factor B 
(SIII) polypeptide 1 2.5
 
  
 
 0.1 3.3 
 
 
 
 0.4
 
Gene expression analysis by cDNA microarrays was performed as described in
Microarray analysis. Only genes that were found to be induced 
 
 
 
1.8-fold upon
bacterial stimulation of both CEACAM1 and 6 are listed (Fig. S2). 
 
a
 
Values represent means of -fold induction (compared with uninfected cells) 
 
 
 
 SD
of three comparisons performed in different dye configurations.
Figure 3. CEACAM1 and 6 engagement stimulate CD105 ex-
pression. (A) Control-transfected (pcDNA) or CEACAM1
(CEA1)-expressing 293T or ME-180 cells were left uninfected or
were infected for 8 h with OpaCEA  N. gonorrhoeae (Ngo
Opa CEA). After RNA isolation, fragments of CD105 and  -actin
mRNA were coamplified by RT-PCR (top), and the ratio of both
signals from each sample was determined by densitometry (bot-
tom). Bars represent the fold induction of infected compared with
uninfected cells. A plasmid encoding full-length CD105 served
as a positive control (pCD105). (B) Expression of CEACAM1 by
the cells used in A, as analyzed by Western blotting of whole
cell lysates (WCL) with mAb  -CEACAM. (C) Expression of
CEACAM1 WT, CEACAM1  CT, and CEACAM6 by the cells
used in D and E (analyzed as in B). (D) Transfected 293T cells
were infected for the indicated times (in hours) with Ngo OpaCEA
or nonopaque gonococci (Ngo Opa ). CD105 mRNA levels
were detected as in A. (E) Transfected 293T cells were infected
for the indicated times with Ngo OpaCEA. CD105 mRNA levels
were detected as in A.CEACAM ENGAGEMENT ENHANCES CELL ADHESION • MUENZNER ET AL. 829
have been described to firmly bind to CEACAMs (Virji et al.,
2000). Examples include Haemophilus influenzae and Mo-
raxella catarrhalis, which target human CEACAMs by distinct
adhesins (Hill et al., 2001; Hill and Virji, 2003). Therefore,
CEACAM1-expressing 293T cells were infected with H. influ-
enzae, M. catarrhalis, or nonpathogenic N. cinerea for 3 or 8 h,
and CD105 mRNA levels were detected by RT-PCR. Impor-
tantly, both CEACAM-binding pathogens led to a marked in-
crease in CD105 mRNA within 3–8 h after infection, whereas
non-CEACAM–binding N. cinerea did not influence CD105
mRNA levels (Fig. 4 B). Enhanced levels of CD105 mRNA
were directly correlated to the presence of detectable amounts
of CD105 on the surface of CEACAM-expressing cells after
infection with OpaCEA gonococci (Fig. 4 C). Infection of
CEACAM-deficient cells with OpaCEA gonococci or infec-
tion of CEACAM1-expressing cells with nonopaque bacteria
or OpaHSPG-expressing gonococci did not result in elevated
CD105 levels (Fig. 4 C and Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200412151/DC1). Together,
these data corroborated the findings of the microarray analysis
and demonstrated that engagement of CEACAMs by several
bacterial pathogens triggers characteristic gene expression
events that lead to elevated levels of CD105 on human epithe-
lial cells.
Suppression of CD105 up-regulation 
abrogates enhanced cell adhesion upon 
bacterial CEACAM engagement
To investigate whether the observed up-regulation of CD105
could be required for bacteria-induced cell adhesion, 293T
cells were cotransfected with CEACAM1 cDNA, and an anti-
sense oligonucleotide was directed against CD105. The anti-
sense oligonucleotide was complementary to sequences span-
ning the AUG start codon on the CD105 mRNA and has been
shown to specifically suppress CD105 expression in human
vascular endothelial cells (Li et al., 2000). In contrast to un-
treated cells or to cells receiving a scrambled control oligonu-
cleotide, CEACAM1-expressing 293T cells that were treated
with the CD105 antisense oligonucleotide did not exhibit
CD105 up-regulation upon infection with CEACAM-bind-
ing gonococci (Fig. 5 A and Fig. S4, available at http://
www.jcb.org/cgi/content/full/jcb.200412151/DC1). Impor-
tantly, the blockage of CD105 up-regulation by antisense oli-
gonucleotide treatment also abolished increased cell adhesion
in response to OpaCEA gonococci in a dose-dependent manner
(Fig. 5 B). The cotransfection of 293T cells with the scrambled
control oligonucleotide had no effect on bacteria-induced cell
Figure 4. CEACAM engagement by human pathogens triggers
up-regulation of CD105 mRNA and protein levels. (A) Control-
transfected (pcDNA) or CEACAM1-expressing 293T cells were
left uninfected or were infected with OpaCEA  N. gonorrhoeae
(Ngo OpaCEA) or piliated N. gonorrhoeae (Ngo P ) for the
indicated times. After RNA isolation, fragments of CD105 and
 -actin mRNA were coamplified by RT-PCR. A plasmid encoding
full-length CD105 served as a positive control (pCD105). (B) 293T
cells transfected as in A were left uninfected or were infected
with Ngo OpaCEA, M. catarrhalis (Mcat), N. cinerea (Ncin), or
H. influenzae (Hinf) for the indicated times. CD105 mRNA levels
were analyzed as in A. (C) 293T cells transfected as in A were left
uninfected or were infected as indicated for 14 h. Cells were de-
tached, stained with monoclonal  -CD105 or control mouse IgG
(control), and analyzed by flow cytometry. FSC-H, forward scatter;
FL1-H, intensity of the signal detected in fluorescence channel 1.
Figure 5. CD105 up-regulation is necessary to mediate increased cell
adhesion. (A) 293T cells were cotransfected with the empty vector
(pcDNA) or CEACAM1 and 400 nM of either CD105 antisense oligo-
nucleotide (AS ODN) or a scrambled control oligonucleotide (SC ODN),
respectively. After 8 h of infection with Ngo OpaCEA, CEACAM1 and
CD105 expression were determined by flow cytometry. Bars represent the
percentage of CEACAM1- or CD105-positive cells of a representative
experiment repeated three times with similar results. (B) 293T cells were
treated as in A using the indicated amounts of antisense or scrambled control
oligonucleotides, respectively. After 8 h of infection with Ngo OpaCEA,
cells were used in adhesion assays. Error bars represent means   SD of
eight samples. Statistical significance was determined by a two-tailed t test.
Collagen-plated samples that differed significantly (P   0.001) from the
infected CEACAM1-expressing cells in the absence of oligonucleotides
are marked by an asterisk.JCB • VOLUME 170 • NUMBER 5 • 2005 830
adhesion (Fig. 5 B). These results suggested that CD105 up-
regulation is necessary to promote cell adhesion upon bacterial
engagement of CEACAMs.
CD105 expression is sufficient to 
promote host cell adhesion and to 
prevent bacteria-induced cell detachment
To investigate whether enhanced expression of CD105 is suffi-
cient to promote epithelial cell adhesion, 293T cells were trans-
fected with cDNA encoding full-length human CD105, and
their adhesive properties were compared with CEACAM1-
transfected cells before and after infection with OpaCEA gono-
cocci. Strikingly, CD105 overexpression in 293T cells in the
absence of bacterial infection led to increases in cell adhesion
similar to those observed after infection of CEACAM-positive
cells with OpaCEA gonococci (Fig. 6 A). CD105 overexpression
enhanced cell adhesion to collagen and also increased cell adhe-
sion to gelatine, matrigel, and, to a lesser extent, fibronectin
(Fig. S5 A, available at http://www.jcb.org/cgi/content/full/
jcb.200412151/DC1). 293T cells overexpressing CD105 were
resistant to bacteria-induced detachment even after prolonged
infection with both CEACAM-binding and nonbinding micro-
organisms, which is consistent with a role for CD105 in the pre-
vention of epithelial cell detachment (Fig. 6 B). Altogether,
these results demonstrated that enhanced surface expression of
CD105 is sufficient to mediate increased cell adhesion to ECM
substrates and to prevent epithelial cell detachment after bacte-
rial engagement of CEACAMs.
The COOH-terminal domain of CD105 is 
required to promote host cell adhesion 
and to prevent bacteria-induced cell 
detachment
Recently, several molecular connections between the cytoplas-
mic domain of CD105 and focal adhesion–associated mole-
cules have been reported that allow CD105 to modulate cyto-
skeletal organization and focal adhesion composition (Conley
et al., 2004; Sanz-Rodriguez et al., 2004). Therefore, we gener-
ated variants of CD105 with either a deletion of the complete
47–amino acid COOH-terminal cytoplasmic tail (CD105  CT)
or a deletion of the last 35 amino acids (CD105  35). In con-
trast to 293T cells that were transfected with wild-type CD105
(CD105 WT), the expression of these CD105 variants did not
result in elevated cell adhesion on collagen (Fig. 6 C), although
they were expressed at similar levels compared with CD105
WT (Fig. S5 B). In addition, compromising the cytoplasmic
domain of CD105 also abolished the ability of CD105-express-
ing cells to withstand bacteria-induced cell detachment (Fig. 6
D). This suggests that molecular connections of the CD105
COOH-terminal domain that influence focal adhesion compo-
sition are important to modify cell adhesive properties and to
counteract cell detachment in response to bacterial infection.
CD105 requires the presence of  1 
integrins to enhance cell adhesion
Because the enhanced cell adhesion that was triggered by
CD105 was most pronounced on surfaces coated with ligands
for  1 integrins, we wondered whether this process involved
integrins. Cell adhesion assays that were performed in the pres-
ence of monoclonal antibodies directed against either CD105,
integrin  1, or the hyaluronate receptor CD44 demonstrated
that interference with both CD105 or integrin  1 abolished en-
hanced cell adhesion after bacterial infection or CD105 expres-
sion (Fig. 7 A). In contrast, anti-CD44 antibodies or control
mouse IgG had no influence on cell adhesion to collagen (Fig.
7 A). Importantly, CD105 expression did not lead to enhanced
cell adhesion in cells that were genetically deficient for integrin
 1, whereas reexpression of human integrin  1 restored the
ability of these cells to display enhanced cell adhesion upon
CD105 expression, demonstrating that integrin  1 is essential
for this process (Fig. 7 B). Flow cytometry revealed that the
levels of integrin  1 are not modulated by the presence of
Figure 6. CD105 is sufficient to promote cell adhesion and to prevent
bacteria-induced cell detachment. (A) 293T cells were transfected as indicated
and were infected or left uninfected for 8 h with OpaCEA-expressing N.
gonorrhoeae. Cells were used in adhesion assays. Bottom panel depicts
Western blots of whole cell lysates (WCL) from transfected cells. (B) 293T
cells transfected with empty vector (pcDNA), CEACAM1, CEACAM6, or
CD105-GFP were infected for 14 h with the indicated bacterial strains.
Cells were used in a detachment assay before microphotographs were
taken. (C) 293T cells were transfected with empty vector (pcDNA), CD105
WT, CD105  CT, or CD105  35 and were used in adhesion assays.
Error bars represent means   SD of five samples (A) or wells (C). (D) 293T
cells transfected as in C were seeded in 24-well plates, and photographs
were taken before infection. Cells were then infected for 14 h with the
indicated bacterial strains and were used in a detachment assay before
remaining cells were photographed.CEACAM ENGAGEMENT ENHANCES CELL ADHESION • MUENZNER ET AL. 831
CD105 (Fig. 7 C). Furthermore, CD105 expression did not al-
ter the production of ECM proteins, such as collagen or fi-
bronectin, by 293T cells (Fig. 7 D), suggesting that CD105
exerts its effect by altering the ligand-binding properties of
integrin  1.
CD105 modulates integrin activity
A characteristic property of integrins is their ability to switch
from a low to a high affinity state with respect to ligand bind-
ing in a process termed integrin activation (Hynes, 2002). Inte-
grin activation can be promoted by signals from within the cell
(inside-out signaling) by long-range conformational changes
that reposition the ligand-binding site of the heterodimeric re-
ceptor and allow substrate binding (Xiao et al., 2004). To in-
vestigate whether CD105 expression has an influence on inte-
grin activation, we incubated cells expressing GFP, CD105
WT, or CD105  CT with microsphere beads coated with either
BSA as a control or integrin  1 ligand collagen. After gentle
washing, GFP-positive cells as well as cell-bound beads were
visualized to allow an estimate of integrin activation on the sin-
gle cell level (Fig. 8 A). Strikingly, there was a strong and se-
lective binding of collagen-coated beads to CD105 WT–trans-
fected cells. Untransfected, GFP-transfected, or CD105  CT–
expressing cells exhibited very little binding of collagen-coated
beads that was indistinguishable from the low background
binding of BSA control beads (Fig. 8 A). In addition, beads that
were coated with an antibody directed against integrin  1
bound equally to all transfected as well as untransfected cells,
demonstrating that integrin levels were not altered by CD105
expression and further indicating that CD105 influences inte-
grin activity (Fig. 8 A). Quantification of the mean number of
beads that were bound per cell corroborated the view that
CD105 WT–expressing cells have a higher collagen-binding
capacity as a result of increased integrin activity and not as a
Figure 7. CD105 cooperates with integrin  1 to mediate enhanced cell
adhesion. (A) 293T cells were transfected with control vector (pcDNA),
CEACAM1, or CD105 WT; infected (black bars) or left uninfected (white
bars) for 8 h with Ngo OpaCEA; and used in adhesion assays in the absence
or presence of mAbs against CD105, integrin  1 ( Int 1), CD44, or with
control mouse IgG. (B) Integrin-deficient fibroblasts (GD25 cells) or GD25
cells expressing human integrin  1 were transfected with CD105-GFP or
the empty vector control (pEGFP) and were used in adhesion assays. Bars
represent means   SD of five (A) or eight wells (B). Bottom panel shows
Western blotting of whole cell lysates with anti-GFP antibody. (C) 293T
cells transfected as in B were stained with anti–integrin  1 antibodies
(clone P5D2) and phycoerythrin (PE)-conjugated secondary antibodies
(black). Controls (gray lines) were stained with isotype-matched control
IgG. Upon gating of GFP-positive cells, phycoerythrin-derived fluorescence
was measured in 10,000 transfected cells. A representative experiment
that was repeated three times is shown. FL2-H, intensity of the fluorescence
signal detected in channel 2. (D) 293T cells were transfected as in C
or were left untransfected (control). 2 d later, whole cell lysates as well
as purified collagen type IV (Col) and fibronectin (FN) as positive con-
trols were analyzed by Western blotting with antibodies against either
collagen type IV (top left) or fibronectin (top right). After stripping, the
membrane was developed with anti– -actin antibodies demonstrating
equal loading (bottom).
Figure 8. CD105 expression results in enhanced integrin activity. (A)
293T cells were transfected as indicated and seeded on glass coverslips.
The cells were either incubated with collagen- (col),  –integrin  1- ( -int),
or BSA-coated microspheres for 2 h at 37 C. Nonadherent beads were
removed by washing with PBS, and the cells were fixed and analyzed by
microscopy. Arrowheads indicate transfected cells. (B) Quantification of
cell-associated beads from samples shown in A. Bars represent the mean
number of beads per transfected cell   SD observed in three independent
experiments in which 60 transfected cells for each sample were counted.
(C) 293T cells expressing either RFP (red arrows) or CD105-GFP (green
arrowheads) were mixed and plated together on glass coverslips. Cells
were incubated with collagen- or  –integrin  1 antibody–coated micro-
spheres for 2 h, washed, fixed, and analyzed by microscopy. Shown are
representative fields of view.JCB • VOLUME 170 • NUMBER 5 • 2005 832
result of changes in integrin expression (Fig. 8 B). To finally
demonstrate the cis-acting properties of CD105 on cell adhe-
sion, cells expressing either RFP or CD105 WT–GFP were
mixed, plated, and incubated with collagen-coated or anti–inte-
grin  1-coated microspheres (Fig. 8 C). Whereas beads coated
with the integrin  1 antibody bound equally well to both cells,
the collagen-coated beads bound with high affinity almost ex-
clusively to the CD105 WT–GFP-expressing cells (Fig. 8 C).
Together, these results support the idea that CD105 positively
influences integrin activation via its cytoplasmic domain,
thereby increasing integrin affinity for ECM proteins and lead-
ing to enhanced cell adhesion.
Various CEACAM-binding bacteria 
enhance host cell adhesion
Up-regulation of CD105 via CEACAM engagement could be a
general mechanism that is used by multiple human-specific
pathogens to prevent epithelial cell detachment. To analyze
whether other CEACAM-binding bacteria are able to trigger en-
hanced cell adhesion to collagen, 293T cells were transfected
with CEACAM1 and were infected with a variety of gram-neg-
ative CEACAM-binding bacteria, including N. meningitidis,
H. influenzae, and M. catarrhalis. As a positive control, cells
were transfected with human CD105. As observed previously,
the expression of human CD105 was sufficient to enhance 293T
cell adhesion to collagen (Fig. 9). Plating of the infected cells
onto collagen-coated surfaces again revealed a strong increase
in cell adhesion in response to OpaCEA-expressing, but not to
nonopaque, gonococci (Fig. 9). Importantly, all CEACAM-
binding microorganisms were able to significantly induce cell
adhesion to collagen, whereas an attachment to uncoated cell
culture surface was unaltered (Fig. 9). Together, these results
demonstrate that a variety of CEACAM-binding bacteria is able
to trigger enhanced epithelial cell adhesion to ECM proteins
and suggest that this might be a common strategy to facilitate
the colonization of epithelial cell layers of their human host.
Discussion
Interestingly, several gram-negative microbes such as H. influen-
zae, N. gonorrhoeae, N. meningitidis, or M. catarrhalis, which
colonize human mucosal surfaces as their sole natural habitat,
exploit members of the human CEACAM family (Hauck, 2002).
Therefore, it has been suggested that CEACAM recognition
might represent a specific adaptation of these bacteria to success-
fully occupy their narrow environmental niche (Virji et al., 2000;
Hauck, 2002). Indeed, according to the results presented in this
study, CEACAM engagement not only allows intimate attach-
ment to host tissues but may also provide these microbes with
means to blunt an innate defense mechanism of the mucosa (i.e.,
the exfoliation response of epithelial cells). In particular, we
demonstrate that bacterial stimulation of CEACAMs triggers en-
hanced host cell adhesion to the ECM, thereby counteracting the
infection-induced detachment of epithelial cells.
Microorganisms have elaborated an array of adhesive fac-
tors, allowing them to firmly attach to host surfaces (Finlay and
Falkow, 1997; Abraham et al., 1998). However, stratified epithe-
lial tissues can rapidly respond to bacterial attachment with ac-
celerated renewal, including detachment of superficial cell layers
as well as differentiation of basal and intermediate cells (Mulvey
et al., 2000; Mysorekar et al., 2002). Infection of the mouse blad-
der with uropathogenic Escherichia coli has demonstrated that
within 6 h after bacterial inoculation, detachment of bacteria-
laden superficial epithelial cells can be detected in vivo (Mulvey
et al., 1998). In the same time frame, urothelial gene expression
is altered to reflect the microbe-induced renewal of the epithelial
strata (Mysorekar et al., 2002). It is interesting to note that
CD105 up-regulation and increased adhesion of epithelial cells
after CEACAM stimulation can be observed within 3–8 h upon
infection. This is consistent with the idea that the impaired de-
tachment of epithelial cells colonized via CEACAMs could
operate to effectively counteract the exfoliation response.
CD105 is a nonsignaling member of the TGF- 1 receptor
family (type III receptor) that is known to modulate cellular re-
sponses to this growth factor (Lebrin et al., 2004). Although the
role of CD105 in TGF- 1 signaling is far from understood
(Fonsatti et al., 2001), CD105 has an essential function in estab-
lishing a well-differentiated vasculature (Li et al., 1999; So-
rensen et al., 2003). Accordingly, mutations in CD105 are found
in hereditary hemorrhagic telangiectasia type 1, which is a hu-
man disease characterized by vascular malformations (McAllis-
ter et al., 1994). In addition, an antiapoptotic function has been
reported for CD105 in endothelial cells, where CD105 is in-
duced upon hypoxia (Li et al., 2003; Zhu et al., 2003). However,
we did not observe differences in apoptosis upon infection of
CEACAM1-expressing cells with OpaCEA-expressing gonococci
compared with cells that were infected with nonopaque bacteria
(unpublished data). Clearly, de novo CD105 expression in hu-
man epithelial cells has a positive influence on cell adhesion to
the ECM in the absence of bacterial infection, further suggest-
ing that the ability of CD105 to counteract the detachment of in-
fected cells is not caused by an antiapoptotic effect.
Interestingly, the adhesion-promoting activity of CD105
mapped to the last 35 residues of the 47–amino acid-long cyto-
Figure 9. Diverse CEACAM-binding human-specific microorganisms
trigger enhanced cell adhesion. 293T cells were transfected with CEACAM1
(black bars) or CD105-GFP (white bars). Cells were left uninfected or were
infected for 8 h with OpaCEA N. gonorrhoeae (Ngo OpaCEA), Opa-expressing
N. meningitidis (Nme OpaCEA), H. influenzae (H. inf.), M. catarrhalis
(M. cat.), or nonopaque N. gonorrhoeae (Ngo Opa ) and were used in
adhesion assays. Error bars represent means   SD of five wells.CEACAM ENGAGEMENT ENHANCES CELL ADHESION • MUENZNER ET AL. 833
plasmic domain. These results are in accordance with recent in-
vestigations that have revealed a novel function for CD105 in
modulating the actin cytoskeleton and cell migration (Liu et al.,
2002; Conley et al., 2004; Sanz-Rodriguez et al., 2004). In par-
ticular, two recent studies have demonstrated that the cytoplas-
mic tail of CD105 interacts with the LIM (Lin-11, Isl-1, and
Mec-3) domains of zyxin and ZRP-1 (zyxin-related protein 1),
respectively, and the presence of CD105 redistributes zyxin and
ZRP-1 from their regular localization at focal adhesion sites
(Conley et al., 2004; Sanz-Rodriguez et al., 2004). Zyxin and
ZRP-1 bind to members of the p130
CAS family of adaptor mole-
cules that, together with their binding partners FAK, c-Src, and
c-Crk, play important roles in cell motility and are involved in
the turnover of focal adhesion structures (Honda et al., 1998;
Klemke et al., 1998; O’Neill et al., 2000; Yi et al., 2002). Impor-
tantly, CD105 expression not only disturbs the focal adhesion as-
sociation of zyxin and ZRP-1 but also disturbs the subcellular
distribution of p130
CAS and c-Crk (Conley et al., 2004). These
molecular interactions might allow CD105 to influence focal ad-
hesion composition and, thereby, impact cell adhesion.
It is important to note that CD105-triggered adhesion
was most pronounced on substrates encompassing integrin  1
ligands such as collagen type I or IV and laminin (the major
constituents of matrigel; Hynes, 2002). Whereas CD105 ex-
pression had no influence on the expression of matrix proteins
or on the surface expression levels of integrin  1, enhanced ad-
hesion could be blocked by antibodies directed against this in-
tegrin. In addition, cells that were genetically deficient for inte-
grin   1 showed no increase in cell adhesion upon CD105
expression. The affinity of integrins for their substrate can be
altered by signals from within the cell (integrin activation) that
modulate the association of focal adhesion proteins such as
talin with integrin  1 cytoplasmic domains (Tadokoro et al.,
2003). As CD105 expression did not affect the total amount of
integrin  1 but affected the ligand-binding capabilities of inte-
grins, we suggest that CD105 positively influences integrin ac-
tivity by modulating the protein composition of integrin-depen-
dent cell attachment sites, thereby influencing integrin activity
by inside-out signaling.
The intriguing molecular cross talk that is revealed in this
study sheds light onto an unexplored process in the establish-
ment of infectious disease; namely, how bacterial pathogens
overcome the exfoliation response of epithelial cells. A surpris-
ing, yet simple, solution to this challenge might be the patho-
gen-triggered modulation of host cell adhesion, as examplified
in this study in the case of diverse CEACAM-binding human-
specific microorganisms. In vivo, bacteria-triggered up-regula-
tion of CD105 via CEACAM engagement and the resulting sup-
pression of epithelial cell detachment could provide CEACAM-
binding microorganisms with a selective advantage during ini-
tial colonization of the human mucosa. It is interesting to specu-
late that such an advantage could be the major driving force be-
hind the convergent evolution of distinct CEACAM-binding
adhesins in several gram-negative species of the genera Neis-
seria, Haemophilus, and Moraxella (Hill et al., 2001; Hauck
and Meyer, 2003; Hill and Virji, 2003). Aside from bacterial
colonization, the functional link between CEACAMs, CD105,
and integrin activation could also play important roles in physi-
ological settings such as angiogenesis (Ergun et al., 2000; Leb-
rin et al., 2004) and warrants further investigation.
Materials and methods
Cell culture and transfection
The human cervix carcinoma cell line ME-180 (American Type Culture
Collection) and the embryonic kidney cell line 293T were cultured in DME
containing 10% calf serum (CS). 14 h before adhesion assays or before
infection, cells were serum starved with DME containing 0.5% CS. 293T
cells were transfected by calcium phosphate coprecipitation using 5  g of
plasmid DNA for each 10-cm culture dish. In some experiments, cells were
cotransfected with plasmid DNA and 0.1, 0.25, or 0.4  M of either
CD105 antisense oligonucleotide or a scrambled control oligonucleotide
(Li et al., 2000). Integrin  1–deficient mouse embryo fibroblasts (GD25
cells) and GD25 cells reexpressing human  1 integrins were provided by
R. Fässler (Max-Planck Institute for Biochemistry, Munich, Germany) and
were cultured as previously described (Wennerberg et al., 1996). Fibro-
blasts were transfected using LipofectAMINE Plus (Invitrogen) according to
manufacturer’s instructions.
Bacteria and infection
The following strains were provided by T. Meyer (Max-Planck Institut für
Infektionsbiologie, Berlin, Germany): Opa52-expressing (OpaCEA) non-
piliated  N. gonorrhoeae MS11-B2.1 (strain N309); Opa50-expressing
(OpaHSPG) nonpiliated N. gonorrhoeae MS11-B2.1 (strain N303); nono-
paque, piliated gonococci (strain N280); nonpiliated, nonopaque gono-
cocci (strain N302); and commensal N. cinerea. Opa-expressing nonen-
capsulated N. meningitidis (SiaD mutant of strain MC58) was obtained
from M. Frosch (Institut für Hygiene und Mikrobiologie, Universität
Würzburg, Germany). M. catarrhalis strain 11994 was obtained from
DSMZ. M. catarrhalis and all Neisseriae species were grown on GC agar
plates (Difco BRL) supplemented with vitamins at 5% CO2 and 37 C and
were subcultured daily. The unencapsulated variant of H. influenzae strain
RD was obtained from A. Reidl (Zentrum für Infektionsforschung, Univer-
sität Würzburg, Germany). H. influenzae was grown on brain–heart infu-
sion agar at 5% CO2 37 C. For infection, bacteria were suspended in
DME, the OD of the suspension was used to estimate the number of micro-
organisms, and bacteria were added to cells at the indicated multiplicity
of infection (MOI).
Recombinant DNA constructs
Mammalian expression plasmids encoding cDNAs of human CEACAM1-4L
(CEACAM1) and CEACAM6 were provided by W. Zimmermann (Univer-
sitätsklinikum Grosshadern, München, Germany). CEACAM1  CT was con-
structed by PCR amplification with primers CEACAM1 sense (5 -GGG-
AAGCTTGCCATGGGGCACCTCTCAGCCCCACTTCAC-3 ) and CEA1-
HA- CT antisense (5 -GGGGACGTCATAGGGATATTTCCCGAAATGCA-
GAAAACATGCCAGGGC-3 ) and were cloned into the HindIII-AatII–
digested plasmid pBluescript CEACAM3-HA (Schmitter et al., 2004) before
further subcloning via HindIII-NotI into pcDNA3.1 Hygro (Invitrogen). Plas-
mid pDS red encoding RFP was from BD Biosciences. A cDNA clone encod-
ing human CD105 (endoglin) was obtained from Deutsches Ressourcenzen-
trum für Genomforschung GmbH (RZPD; clone ID IMAGp958J07537QZ).
Amplification of full-length CD105 was performed by using the primer pair
EndoIF sense (5 -GAAGTTATCAGTCGATACCATGGACCGCGGCACGC-
TCCCTCTGGC-3 ) and EndoIF antisense (5 -ATGGTCTAGAAAGCTTCCT-
GCCATGCTGCTGGTGGAGCAGGGGGTGC-3 ). CD105 variants with
deletions in the cytoplasmic domain were generated by amplification from
the same template using the primer EndoIF sense combined with either En-
doIF  CT antisense (5 -ATGGTCTAGAAAGCTTCCCCAGAGTGCAGCAG-
TGAGCAGGGC-3 ) or EndoIF  35 antisense (5 -ATGGTCTAGAAAGC-
TTTCCCGCTTGCTGGGGGAACGCGTGTGCG-3 ) to result in CD105  CT
or CD105  35, respectively. The resulting PCR fragments were cloned
into pDNR-Dual using the In-Fusion PCR Cloning Kit (BD Biosciences) and
were transferred by Cre-mediated recombination into pLPS-3  EGFP (BD
Biosciences), resulting in GFP fused to the COOH terminus of the ex-
pressed proteins.
EM
ME-180 cells were seeded at 2.5   10
5 cells/well in 24-well plates on
acid-washed glass coverslips that were coated with 25  g/ml collagen.
The next day, medium was replaced with DME and 0.5% CS for 8 h.JCB • VOLUME 170 • NUMBER 5 • 2005 834
Then, cells were infected for 14 h at an MOI of 20 or were left uninfected.
Samples were fixed in situ with 2% glutaraldehyde/3% formaldehyde in
0.1 M cacodylate, 0.09 M sucrose, 0.01 M CaCl2, and 0.01 M MgCl2,
pH 6.9, for at least 1 h at 4 C. The samples were washed with 20 mM
Tris and 1 mM EDTA, pH 7.0, and were dehydrated in a graded series of
aceton on ice. After critical point drying from liquid CO2, samples were
sputter coated with 10-nm gold and examined at 5 kV of accelerating volt-
age in a field emission scanning electron microscope (model DSM982
Gemini; Carl Zeiss MicroImaging, Inc.) using Everhardt Thornley and in-
lense secondary electron detectors (Carl Zeiss MicroImaging, Inc.) in a
1:1 ratio. Images were digitally recorded and processed in Adobe Photo-
shop 6.
Detachment assay
ME-180 cells were seeded at 2   10
4 cells/well onto collagen-coated
(16 h at 4 C) wells of 96-well plates. The next day, growth medium was re-
placed with DME containing 0.5% CS, and after 8 h, the confluent mono-
layers were infected or left uninfected for 14 h with the indicated bacteria
at an MOI of 20. In some cases, aliquots of sample that were infected for
14 h were used for the determination of viable bacteria by dilution plating
onto GC agar. After infection, plates were either fixed in situ or inverted
and centrifuged for 5 min at 2,500 rpm to remove detached cells and me-
dium before fixation with 4% PFA (20 min at RT). Samples were stained
with 0.1% crystal violet in 0.1 M borate, pH 9.0 (CV stain). The staining
intensity was measured in a microplate reader (Bio-Rad Laboratories) at
570 nm. The percentage of detached cells was determined by comparing
samples fixed before and after centrifugation. 293T cells were seeded at
10
5 cells/well in a 24-well plate coated with 25  g/ml collagen type I (in
PBS for 16 h at 4 C) and infected with an MOI of 20 for 14 h. Cells were
washed with PBS, fixed, stained with CV stain, and photographed.
Cell adhesion assay
The wells of 96-well plates were coated with 100  l PBS containing the in-
dicated concentrations of collagen (collagen type 1 from calf skin [ICN
Biomedicals], gelatine [Merck], matrigel [BD Biosciences], and bovine fi-
bronectin [ICN Biomedicals]) or 0.2% BSA, respectively, for 24 h at 4 C.
Serum-starved cells were infected or left uninfected with the indicated bac-
teria at an MOI of 30 for 8 h in the absence or presence of cycloheximide
or staurosporine (Calbiochem). Then, the cells were detached by limited
trypsin/EDTA digestion that was stopped by the addition of 0.5 mg/ml of
soybean trypsin inhibitor in DME. Detached cells were kept in suspension
medium (DME and 0.2% BSA) for 1 h at 37 C and were replated at 2  
10
4 cells/well onto protein-coated wells in replicates of five. Where indi-
cated, 1  g/ml mAbs against CD105 (clone P4A4; Developmental Stud-
ies Hybridoma Bank [DSHB], under the auspices of the National Institutes
of Child Health and Human Development), integrin  1 (clone P5D2;
DSHB), CD44 (clone H4C4; DSHB), or mouse IgG were present during re-
plating. After 90 min at 37 C, nonadherent cells were removed by wash-
ing with PBS, adherent cells were fixed and stained with CV stain, and the
staining intensity was measured.
Microarray analysis
Total RNA was isolated from pcDNA, CEACAM1, or CEACAM6-trans-
fected 293T cells 90 min after infection with OpaCEA-expressing N. gonor-
rhoeae or from the corresponding uninfected cells using the RNeasy kit
(QIAGEN). 15  g RNA was reverse transcribed into cDNA in the pres-
ence of fluorescently labeled nucleotides (Cy3 or Cy5) using the CyScribe
First Strand cDNA kit (GE Healthcare). For each sample, reverse transcrip-
tion and labeling was performed once in the presence of Cy3- and Cy5-
labeled nucleotides. Labeled cDNA populations from an infected sample
and the corresponding uninfected sample were hybridized in both dye
configurations to custom-made cDNA microarrays using a Slide Pro sta-
tion (Lucidea; GE Healthcare). The arrays contained PCR products with a
mean size of 1,000 bp, which was derived from 4,500 mostly cancer-asso-
ciated genes (generated from cDNA templates that were obtained from
RZPD). A scheme of the different hybridizations is outlined in Fig. S2. After
extensive washing, fluorescence of the Cy3- as well as the Cy5-labeled
cDNA population that was hybridized to the slide was recorded with a
ScanArray (model 4000; PerkinElmer), and 16-bit images for each fluores-
cence channel were generated. The resulting raw data were transformed
into spot intensities by ScanAlyze 2 software (obtained from M. Eisen,
University of California, Berkeley, Berkeley, CA). The data obtained for
each hybridization experiment were normalized by using the whole set of
measurements, and genes that were up-regulated  1.8-fold independently
of the dye configuration in two repetitions of the experiment were re-
garded as induced by bacterial infection.
RT-PCR analysis
Total RNA was isolated from the indicated cells at different time points after
infection by using the RNeasy kit and were further treated with RNase-free
DNase-I (QIAGEN). 2  g RNA were reverse transcribed into cDNA using
SuperscriptIIRT and oligonucleotide (desoxythymidine) primers (Invitrogen).
RNA that was used directly for PCR amplification did not yield any PCR
product, indicating that signals were not caused by chromosomal DNA
contamination. The amplification of a 640-bp fragment of human CD105
was performed using primers 5 -CGGTGGTAGGCTGCAGACCTCACC-3 
and 5 -CCTATGGACTTCCTGGTCTTGAGACC-3  with 30 cycles of ampli-
fication and an annealing temperature of 58 C. Simultaneously, a 350-bp
fragment of  -actin (primers  -actin sense, 5 -AGCGGGAAATCGTGC-
GTG-3 ; and  -actin antisense, 5 -GGGTACATGGTGGTGCCG-3 ) was
coamplified and served as an internal control.
Flow cytometry and Western blotting
Analyses were performed as described previously (Schmitter et al., 2004)
by using mAbs against CEACAM (clone D14HD11; Genovac), CD105
(clone P4A4; DSHB), fibronectin or  -actin (clone F 3648 or AC-74;
Sigma-Aldrich), and GFP (clone JL-8; BD Biosciences), pAbs against col-
lagen IV (H-243; Santa Cruz Biotechnology, Inc.), and rabbit pAbs
against N. gonorrhoeae (gift of T.F. Meyer, Max Planck Institut für Infek-
tionsbiologie). Secondary antibodies were obtained from Jackson Immu-
noResearch Laboratories.
Covalent coupling of proteins to microspheres and microsphere-binding 
assay
1.2   10
8 polybead carboxylate microspheres (1  m in diameter; Poly-
sciences) were sonicated and covalently coated with either 1 mg/ml col-
lagen type 1, 100  g/ml mAb  –integrin  1 (P5D2; DSHB), or 4 mg/ml
BSA for 2 h in coupling buffer (0.2 M NaHCO3 and 0.5 M NaCl, pH
8.6). Unreacted binding sites were saturated with 20 mg/ml BSA in cou-
pling buffer for 1 h before extensive washing with PBS. To determine bead
attachment to cells, transfected 293T cells were seeded at 2.5   10
5
cells/well in 24-well plates on acid-washed glass coverslips and were in-
cubated with 2.5   10
7 coated microspheres. After 2 h at 37 C, nonad-
herent beads were removed by washing with PBS, and the cells were
fixed and analyzed by microscopy to determine the number of beads that
bound to transfected cells.
Online supplemental material
Fig. S1 shows that bacteria-triggered cell adhesion is blocked by the ki-
nase inhibitor staurosporine. Fig. S2 presents the general layout of mi-
croarray analysis and provides original data of hybridized microarray
slides. Fig. S3 provides evidence that OpaHS-expressing gonococci are un-
able to induce CD105 up-regulation, as analyzed by flow cytometry. Fig.
S4 demonstrates the blockage of bacteria-triggered CD105 up-regulation
by CD105-directed antisense oligonucleotides, as analyzed by flow cy-
tometry. Fig. S5 shows that CD105 promotes cell adhesion to different
ECM proteins and presents the expression of CD105 variants with
COOH-terminal deletions in transfected 293T cells. Online supplemen-
tal material is available at http://www.jcb.org/cgi/content/full/
jcb.200412151/DC1.
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